• Product NameByakangelicin
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityByakangelicin is an antineoplastic agent. Byakangelicin has inhibitory effect on and presence of sulphydryl group in pregnant mare's serum gonadotropin. 3. Byakangelicin markedly induces the expression of CYP3A4 both at the mRNA level and the protein level but do not affect expression of human pregnane X receptor.
• Target NameOthers inhibitor
• CAS No. 19573-01-4
• Calculated MW 334.32
• Formulation C17H18O7
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CC(C)([C@@H](COC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)O)O
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:Soluble in DMSO
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Yang J, et al. Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes. Br J Pharmacol. 2011 Jan;162(2):441-51.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting